
Keywords: AED; antiepileptic drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; EIAED; enzyme-inducing antiepileptic drug; IGE; idiopathic generalised epilepsy; ILAE; International League Against Epilepsy; TEAE; treatment-emergent adverse event; Ant